US 2007/0179175 A1Published application

Tetrahydronaphthyridine Derivative

OwnerGraham Lunninventor

Life of this patent

Estimating the term…

Abstract

The invention relates to 6-[2-(1-Isopropyl-piperidin-4-yloxy)-7,8-dihydro-5H-[1,6]naphthyridin-6-yl]-nicotinamide and to processes for the preparation of, compositions containing and the uses of, the compound. The compound is an H3 ligand and is useful in numerous diseases, disorders and conditions, in particular inflammatory, allergic and respiratory diseases, disorders and conditions.

Claims8

Dependent claims

The compound 6-[2-(1-Isopropyl-piperidin-4-yloxy)-7,8-dihydro-5H-[1,6]naphthyridin-6-yl]-nicotinamide

Dependencies are inferred from the claim text.

Facts

Application: 11/555,927Filed 2 Nov 2006
Priority: 4 Nov 2005
Published: 2 Aug 2007
Term ends: Not estimatedThe source records don’t support an estimate.

Classification27 codes

C07D 471/04
In which the condensed system contains two hetero rings: ortho-condensed systems
A61P 1/04
Drugs for disorders of the alimentary tract or the digestive system: for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of…
A61P 9/02
Drugs for disorders of the cardiovascular system: non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
A61P 9/04
Drugs for disorders of the cardiovascular system: inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Family

Application60/733,590Us provisional application · filed 4 Nov 2005
US 2007/0179175 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results